Previous 10 | Next 10 |
Soligenix Receives Conditional FDA Acceptance of Proposed Brand Name HyBryte™ for SGX301 in CTCL PR Newswire PRINCETON, N.J. , April 7, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical comp...
Soligenix (SNGX): FY GAAP EPS of -$0.64 misses by $0.10.Revenue of $2.4M (-47.8% Y/Y) beats by $0.2M.Shares +4.03% PM.Press Release For further details see: Soligenix EPS misses by $0.10, beats on revenue
Soligenix Announces Recent Accomplishments And Year-End 2020 Financial Results PR Newswire PRINCETON, N.J. , March 30, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developin...
New York, New York--(Newsfile Corp. - March 16, 2021) - PCG Digital -- The future is looking bright at Soligenix, Inc. In a corporate update released on February 24 th , Dr. Christopher Schaber, Chairman, President and CEO, updated investors on the status of ongoing research projects. The re...
Soligenix to Receive $865,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program PR Newswire PRINCETON, N.J. , March 9, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage bioph...
3 Penny Stocks To Watch Even During This Pullback While the last few weeks have been up and down for penny stocks, investors seem hopeful about the future. As we witness the natural ebb and flow of the stock market, there are a few things to be excited about in the coming months. For on...
Gainers: Five Prime Therapeutics (FPRX) +78%, Ampio Pharmaceuticals (AMPE) +10%, Soligenix (SNGX) +7%.Losers: BioVie (BIVI) -29%, Schrodinger (SDGR) -25%, KemPharm (KMPH) -19%, Anchiano Therapeutics (ANCN) -15%, AbCellera Biologics (...
Soligenix, Inc. (SNGX) has added ~13.7% in the pre-market after announcing the publication of pre-clinical immunogenicity studies for CiVax, the company’s heat-stable vaccine candidate for the prevention of COVID-19.According to the company, the article posted as an...
Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine - Broad and potent immune responses demonstrated with full length Spike protein antigen - Large animal studies and COVID variant testing planned - Facilitates development of a h...
Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter PR Newswire PRINCETON, N.J. , Feb. 24, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focus...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's ( Nasdaq:SNGX ) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte...